Form D · Biotechnology
GRAIL, Inc.
Menlo Park, CA · CIK 0001699031
Offering snapshot reported Nov 7, 2025 · SEC filing
- Reported sold
- $325M Offering amount: $325M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2025 | Initial | $324,997,989 | No comparison | 17 | SEC filing |
| May 7, 2020 | Amendment | $388,407,514 | $263,407,514vs Dec 12, 2019 | 14 | SEC filing |
| Dec 12, 2019 | Initial | $125,000,000 | No comparison | 1 | SEC filing |
| May 25, 2018 | Initial | $300,000,000 | No comparison | 14 | SEC filing |
| Jan 11, 2018 | Amendment | $1,214,655,040 | $3,000,001vs Nov 22, 2017 | 59 | SEC filing |
| Nov 22, 2017 | Amendment | $1,211,655,039 | $297,630,099vs Mar 14, 2017 | 58 | SEC filing |
| Apr 26, 2017 | Amendment | $973,248,965 | $59,224,025vs Mar 14, 2017 | 47 | SEC filing |
| Mar 14, 2017 | Initial | $914,024,940 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563405
Source: Form D, filed Nov 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hal Barron | Director |
| Jose Baselga | Director |
| Hans Bishop | Director, Executive |
| Brook Byers | Director |
| William Chase | Director |
| Jennifer Cook | Director, Executive |
| Min Cui | Director |
| Kaye Foster | Director |
| Kaye Foster Cheek | Director |
| Aaron Freidin | Executive |
| Catherine Friedman | Director |
| Maykin Ho | Director |
| Jeffrey Huber | Director |
| Richard Klausner | Director |
| Sarah Krevans | Director |
| Steve Mizell | Director |
| Robert Nelsen | Director |
| Josh Ofman | Executive |
| Robert Ragusa | Director, Executive |
| William Rastetter | Director |
| Gregory Summe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1525 O'brien Drive
Menlo Park, CA, 94025
Menlo Park, CA, 94025